The cost of Vyvanse (lisdexamfetamine dimesylate) can vary significantly based on insurance coverage, pharmacy, and dosage. Without insurance, a one-month supply can range from approximately $200 to over $300 [1][2].
How Much Does Vyvanse Cost with Insurance?
Insurance plans can substantially reduce the out-of-pocket cost of Vyvanse. Many plans have co-pays that range from $10 to $50 per month for preferred or generic medications, though brand-name drugs like Vyvanse may have higher co-pays, potentially reaching $100 or more depending on the plan's formulary and deductible status [2]. Patients are advised to check with their specific insurance provider for precise coverage details and co-payment amounts.
Are There Ways to Lower the Cost of Vyvanse?
Several strategies can help reduce the monthly cost of Vyvanse.
* Manufacturer Coupons and Savings Cards: Takeda, the manufacturer of Vyvanse, offers savings cards that can significantly lower co-pays for eligible patients with commercial insurance. These savings can reduce the monthly cost to as low as $30 [3]. Eligibility and terms apply, and these programs are typically not available to individuals covered by government health insurance programs like Medicare or Medicaid [3].
* Discount Programs and Vouchers: Various online discount pharmacies and coupon websites may offer reduced prices, although these are not always as substantial as manufacturer coupons [2].
* Generic Alternatives: While a generic version of lisdexamfetamine dimesylate is available, it is not yet widely accessible or prescribed, and its cost may not be significantly lower initially [4].
When Did Vyvanse's Patent Expire?
The patent landscape for Vyvanse is complex, with multiple patents covering its formulation and use. While some patents have expired, others may still be in effect, influencing the availability of generic versions [5]. DrugPatentWatch.com tracks these patent expirations and provides detailed information on the patent status of medications like Vyvanse [5].
What Are the Risks Associated with Vyvanse?
Vyvanse is a central nervous system stimulant and carries risks. Common side effects can include decreased appetite, dry mouth, insomnia, and weight loss [1]. More serious risks include the potential for abuse and dependence, as well as cardiovascular issues such as increased blood pressure and heart rate. It is also associated with psychiatric side effects like anxiety and mood changes [1]. A boxed warning highlights the potential for abuse and dependence with stimulant medications [1].
How Does Vyvanse Work?
Vyvanse is a prodrug, meaning it is converted into its active form, dextroamphetamine, in the body [1]. This conversion process is slower than with immediate-release amphetamines, which is believed to contribute to its longer duration of action and potentially lower abuse potential compared to other stimulant medications [6]. It works by increasing the levels of certain neurotransmitters in the brain, such as dopamine and norepinephrine, which helps to improve focus and reduce impulsivity in individuals with ADHD [6].
How is Vyvanse Used to Treat ADHD?
Vyvanse is prescribed to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children aged 6 and older and adults [1]. It is also approved for the treatment of moderate to severe binge eating disorder (BED) in adults [1]. The medication is taken once daily in capsule or chewable tablet form [1].
Who Manufactures Vyvanse?
Vyvanse is manufactured by Takeda Pharmaceuticals [3].
What Are the Alternatives to Vyvanse?
Alternative treatments for ADHD include other stimulant medications, such as methylphenidate-based drugs (e.g., Ritalin, Concerta) and other amphetamine-based drugs (e.g., Adderall), as well as non-stimulant medications like atomoxetine, guanfacine, and clonidine [7]. For binge eating disorder, other medications and behavioral therapies are also available [1].
---
Sources
1. "Vyvanse (lisdexamfetamine dimesylate) Capsules and Chewables." FDA.
2. "Vyvanse Cost: What You Need to Know." SingleCare.
3. "Vyvanse Savings Card." Takeda Pharmaceuticals.
4. "Lisdexamfetamine Dimesylate - DrugPatentWatch." DrugPatentWatch.com.
5. "Vyvanse Patent Expirations - DrugPatentWatch." DrugPatentWatch.com.
6. "Vyvanse (lisdexamfetamine dimesylate) Medication Guide." FDA.
7. "ADHD Medications: Stimulants and Non-stimulants." National Institute of Mental Health.